Viatris (LTS:0A5V) Change In Inventory : $-833 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Viatris Change In Inventory?

Viatris's change in inventory for the quarter that ended in Mar. 2024 was $-370 Mil. It means Viatris's inventory increased by $370 Mil from Dec. 2023 to Mar. 2024 .

Viatris's change in inventory for the fiscal year that ended in Dec. 2023 was $-613 Mil. It means Viatris's inventory increased by $613 Mil from Dec. 2022 to Dec. 2023 .

Viatris's Total Inventories for the quarter that ended in Mar. 2024 was $3,823 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Viatris's Days Inventory for the quarter that ended in Mar. 2024 was 154.09.

Inventory Turnover measures how fast the company turns over its inventory within a year. Viatris's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.59.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Viatris's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.00.

Viatris Change In Inventory Historical Data

The historical data trend for Viatris's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Change In Inventory Chart

Viatris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-512.90

-741.90

-427.60

-259.50

-613.30

Viatris Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-151.10	-115.40	-219.20	-127.60	-370.40

Viatris Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-833 Mil.

Viatris (LTS:0A5V) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Viatris's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	3646.45	/	2159.4	*	365 / 4
	=	154.09

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Viatris's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2159.4	/	3646.45
	=	0.59

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Viatris's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	3646.45	/	3663.4
	=	1.00

Viatris Change In Inventory Related Terms

Thank you for viewing the detailed overview of Viatris's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Viatris (LTS:0A5V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (LTS:0A5V) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

VTRS:USA MYL:Mexico 1VTRS:Italy VIA:Germany MYL:Austria

Address

1000 Mylan Boulevard, Canonsburg, PA, USA, 15317

Website

https://www.viatris.com

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris (LTS:0A5V) Headlines

No Headlines